# Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema

> **NCT01843530** · PHASE3 · COMPLETED · sponsor: **Technical University of Munich** · enrollment: 31 (actual)

## Conditions studied

- Acute ACE-induced Angioedema

## Interventions

- **DRUG:** Berinert
- **DRUG:** Clemastin
- **DRUG:** Cortisone acetate
- **DRUG:** NaCl

## Key facts

- **NCT ID:** NCT01843530
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2018-10-05
- **Final completion:** 2019-09-30
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01843530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01843530, "Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01843530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*